|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Biology, 2 Center for Cancer Research, 3 Computer Science and Artificial Intelligence Laboratory, 4 Biological Engineering Division, and 5 Department of Electrical Engineering & Computer Science, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
(RECEIVED July 1, 2004; FINAL REVISION September 7, 2004; ACCEPTED September 7, 2004)
Phosphopeptide-binding domains, including the FHA, SH2, WW, WD40, MH2, and Polo-box domains, as well as the 14-3-3 proteins, exert control functions in important processes such as cell growth, division, differentiation, and apoptosis. Structures and mechanisms of phosphopeptide binding are generally diverse, revealing few general principles. A computational method for analysis of phosphopeptide-binding domains was therefore developed to elucidate the physical and chemical nature of phosphopeptide binding, given this lack of structural similarity. The surfaces of nine phosphopeptide-binding proteins, representing seven distinct classes of phosphopeptide-binding modules, were discretized, and encoded with information about amino acid identity, surface curvature, and electrostatic potential at every point on the surface in order to identify local surface properties enriched in phosphoresidue contact sites. Cross-validation indicated that propensities corresponding to this enrichment calculated from a subset of the training data could be used to predict the phosphoresidue contact site on proteins not used in training with no false negative results, and with few unconfirmed positive predictions. The locations of phosphoresidue contact sites were then predicted on the surfaces of the checkpoint kinase Chk1 and the BRCA1 BRCT repeat domain, and these predictions are consistent with recent experimental evidence.
Keywords: phosphopeptide-binding domains; BRCA1; Chk1; functional site prediction
Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.04964705.
Reprint requests to: Michael B. Yaffe, MIT Center for Cancer Research, Room E18580, Cambridge, MA 02139, USA; e-mail: myaffe{at}mit.edu; fax: (617) 452-4978; or Bruce Tidor, MIT Computer Science and Artificial Intelligence Laboratory, Room 32-212, Cambridge, MA 02139, USA; e-mail: tidor{at}mit.edu; fax: (617) 252-1816.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. B. Yaffe "Bits" and Pieces Sci. Signal., June 20, 2006; 2006(340): pe28 - pe28. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Yarden and M. Z. Papa BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions. Mol. Cancer Ther., June 1, 2006; 5(6): 1396 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. H. Jia, J. Nie, C. Wu, C. Li, and S. S.-C. Li Novel Src Homology 3 Domain-binding Motifs Identified from Proteomic Screen of a Pro-rich Region Mol. Cell. Proteomics, August 1, 2005; 4(8): 1155 - 1166. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |